The effect of alginate monomer ratio on protein binding and controlled release: application to albumin loaded in alginate microparticles
Related Experiment Video
Updated: May 28, 2026

Generation of Alginate Microspheres for Biomedical Applications
Published on: August 12, 2012
Eyad Almouazen1, Kate Paterson1, Cynthia Barratier1
1Univ Lyon, Université Claude Bernard Lyon 1, CNRS, LAGEPP UMR 5007, 43 Boulevard du 11 Novembre 1918, F-69622 Villeurbanne, France.
Abstract:
Polysaccharide matrices are particularly useful for encapsulation of protein drugs, which is sometimes challenging. The aim of this work was to investigate the impact of the structure of the alginate macromolecule on its affinity with a protein model (bovine serum albumin), and hence protein encapsulation efficiency and release kinetics from the polysaccharide matrix. Indeed, two alginate types, with different monomer ratios were used. Affinity study at physiological pH, with surface plasmon resonance, between alginate and albumin showed that the equilibrium dissociation constant (KD) is approximately 300 times lower for alginate with higher mannuronic/guluronic monomer ratio. The loading of alginate microparticles with albumin was more important at low pH and for the alginate with the higher mannuronic/guluronic ratio. The release, studied in physiological pH, was faster for alginate with the lower mannuronic/guluronic ratio. In conclusion, this work highlights the affinity implication in the design of polysaccharide-based controlled release matrices for the delivery of protein therapeutics.
More Related Videos
12:22Synthesis of Thermogelling PolyN-isopropylacrylamide-graft-chondroitin Sulfate Composites with Alginate Microparticles for Tissue Engineering
Published on: October 26, 2016
07:24Author Spotlight: Advancing Therapeutics with Biocompatible Sodium Alginate Hydrogel Microspheres
Published on: June 7, 2024
Related Concept Videos
Drug Distribution: Plasma Protein Binding
Factors Affecting Protein-Drug Binding: Drug-Related Factors
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In contrast,...
Factors Affecting Protein-Drug Binding: Protein-Related Factors
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be bound by...
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Modified-Release Drug Delivery Systems: Rate-Programmed II